undamentalytics Newsletter

Cronin Kathleen M: insider trades

Officer at CME Group. No open-market purchases and 14 sales not made under a pre-set plan, reported from September 17, 2012 to March 14, 2022.

What happened after Cronin Kathleen M’s sales?

After their sales, the shares moved +3.5% against the index over 12 months on average (a negative figure means selling was the right call); 36% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Cronin Kathleen M: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 14 +0.5% +0.5% 50% 10 −0.08 0.93 No reliable evidence
Sales, 12 months after the report 14 +3.5% +5.5% 36% 10 1.51 0.16 No reliable evidence
Sales, 12 months after the trade 14 +3.9% +8.0% 29% 10 1.71 0.12 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
CME Group CME Sr MD Gen Counsel & Corp Secr014September 17, 2012March 14, 2022

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 14, 2022March 11, 2022 CME Sale $908,600 −3.0%−9.8%−8.7%
June 16, 2021June 14, 2021 CME Sale $881,049 −19.0%+8.7%+7.4%
December 15, 2020December 14, 2020 CME Sale $1,107,569 +7.6%+2.2%+3.3%
December 16, 2019December 13, 2019 CME Sale $688,089 +1.9%−26.0%−27.7%
May 22, 2019May 21, 2019 CME Sale $925,982 +10.5%−8.5%−6.2%
March 18, 2019March 14, 2019 CME Sale $1,397,258 +12.9%+0.8%+13.4%
June 1, 2018May 31, 2018 CME Sale $876,470 −3.1%+15.5%+18.3%
June 15, 2017June 14, 2017 CME Sale $1,034,719 +1.4%+23.7%+21.9%
March 15, 2017March 14, 2017 CME Sale $733,134 −0.5%+20.5%+18.2%
June 7, 2016June 6, 2016 CME Sale $600,408 +8.9%+17.5%+9.8%
November 4, 2014November 3, 2014 CME Sale $162,278 +10.7%+10.3%+11.5%
December 12, 2013December 10, 2013 CME Sale $92,608 −9.2%−0.1%+3.5%
June 13, 2013June 12, 2013 CME Sale $227,789 −6.3%−20.5%−18.3%
September 17, 2012September 13, 2012 CME Sale $155,081 −5.8%+15.0%+8.5%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Cronin Kathleen M traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.